Inside Drug Pricing - 02/10/2020

Azar Lists HHS Efforts To Lower Drug Prices, Except Intl. Price Index

By Ariel Cohen / February 6, 2020 at 5:34 PM
HHS Secretary Alex Azar on Thursday (Feb. 6) touted falling drug prices and his department’s work on drug imports, and he said drug pricing legislation is a top priority, but his State of the Department address did not mention HHS’ biggest potential initiative: tying Medicare reimbursement to international drug prices. He also left out the surprise medical billing legislation that the White House has been working on with Congress. Azar gave his State of the Department address two days after...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.